SWIFT v. PANDEY

District Court, D. New Jersey·Decided July 29, 2022·No. 2:13-cv-00650·Unknown

Opinion

NOT FOR PUBLICATION

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW JERSEY

ROBERT SWIFT, Plaintiff, Case No. 2:13-cv-00650 (BRM) (JSA) v. OPINION RAMESH PANDEY, et al., Defendants. MARTINOTTI, DISTRICT JUDGE Before the Court is pro se Plaintiff Robert Swift’s (“Swift”) Motion for an Adverse Inference. (ECF No. 454.) Defendants Ramesh Pandey (“R. Pandey”) and Bhuwan Pandey (“B. Pandey”) (collectively, “Defendants”) opposed. (ECF No. 457.) Swift replied. (ECF No. 458.) Having reviewed the parties’ submissions filed in connection with the Motion and having declined to hold oral argument pursuant to Federal Rule of Civil Procedure 78(b), for the reasons set forth herein and for good cause shown, the Motion is DENIED WITHOUT PREJUDICE. I. BACKGROUND The Court has set forth, at length, the factual and procedural background as it pertains to this action in its Opinions dated August 10, 2016, March 27, 2017, August 31, 2017, October 12, 2017, May 22, 2018, and May 2, 2022. (ECF Nos. 165, 197, 222, 229, 264, 444.) The Court hereby incorporates same herein and sets forth only the relevant factual and procedural background as it relates to the Motion. This action revolves around an alleged transfer of assets between defendant Xechem (India) Pvt. Ltd. (“Xechem India”) to non-party Xechem International (“International”). (Third Am. Compl. (“TAC”) (ECF No. 85).) In 2013, Swift commenced this action against Defendants. (ECF No. 1.) After substantial motion practice and numerous amendments, the TAC became the operative complaint.1 (ECF No. 85; Sept. 8, 2015 Order (ECF No. 94).) The TAC includes the following allegations: Xechem

India is a private Indian company founded in 1994 and owned by Defendants. (ECF No. 85 ¶¶ 8– 9.) Between July 2000 and April 2007, International loaned $977,394 to Xechem India, expected to be repaid, and, despite demand for repayment, had not been repaid either the principal or interest on the loan. (Id. ¶¶ 14, 46–53.) Audited financial statements document this $977,394 transfer as a loan, and there is no written contract for the loan. (Id. ¶¶ 19, 52.) The money sent by International to Xechem India “was used to the benefit of the only officers and shareholders of Xechem India”, i.e., R. Pandey and B. Pandey, and Xechem India was merely a conduit for their personal finances and business transactions. (Id. ¶¶ 56, 57.) The TAC asserts six causes of action: Count I—“Quantum Meruit by [R. Pandey];” Count II—“Quantum Meruit by [B. Pandey];” Count III—“Quantum Meruit by Xechem India;” Count IV—“Unjust Enrichment by [R.

Pandey]; Count V—“Unjust Enrichment by [B. Pandey];” and Count VI—“Unjust Enrichment by Xechem India.”2 (See generally id.) This case was scheduled for a bench trial on November 15, 2021, but the parties failed to comply with the terms of the final pre-trial order. (ECF Nos. 420, 435.) The Court determined,

1 The TAC was filed on March 27, 2015. (ECF No. 85.) 2 In addition to the unjust enrichment and quantum meruit claims arising out of the alleged loan, the TAC also claims unjust enrichment and quantum meruit against Defendants arising out of an alleged failure by R. Pandey to transfer 66-2/3% of his shares in Xechem India to International. (See generally ECF No. 85.) These claims do not appear to be the subject of the Motion, but to the extent Swift contends Defendants spoliated or withheld evidence relevant to these share transfer claims, the Court declines to grant an adverse inference for the reasons set forth herein. on what was to be the first day of trial, the case was not trial ready. (ECF No. 435 at 40.) The Court nonetheless permitted the parties to present their opening statements, which were followed by a defense motion to dismiss and the Court’s denial of said motion. (ECF Nos. 420, 435.) Thereafter, Swift filed a motion for summary judgment (ECF No. 426), and Defendants cross-

moved for summary judgment (ECF No. 434). On May 2, 2022, the Court denied both motions. (ECF Nos. 444, 445.) On June 8, 2022, Swift filed a motion for an adverse inference. (ECF No. 454.) On July 1, 2022, Defendants filed an opposition. (ECF No. 457.) On July 8, 2022, Swift filed a reply. (ECF No. 458.) The Court denied the Motion orally on the record on July 29, 2022 during a virtual pre-trial conference and notified the parties that it would file this written Opinion and a separate Order. (ECF No. 470.) Trial is scheduled to resume August 9, 2022. (ECF No. 447.) II. LEGAL STANDARD When a document is “relevant to an issue in a case, the trier of fact generally may receive the fact of the document’s nonproduction or destruction as evidence that the party that has

prevented production did so out of the well-founded fear that the contents would harm him.” Brewer v. Quaker State Oil Refining Corp., 72 F.3d 326, 334 (3d Cir. 1995) (citing Gumbs v. Int’l Harvester, Inc., 718 F.2d 88, 96 (3d Cir. 1983); United States v. Cherkasky Meat Co., 259 F.2d 89, 93 (3d Cir. 1958)). For an adverse inference to apply, the moving party must demonstrate “the evidence was in the [nonmoving] party’s control; the evidence is relevant to the claims or defenses in the case; there has been actual suppression or withholding of evidence; and, the duty to preserve the evidence was reasonably foreseeable to the [nonmoving] party.” Bull v. United Parcel Serv., Inc., 665 F.3d 68, 73 (3d Cir. 2012). Further, “a finding of bad faith is pivotal to a spoliation determination . . . since spoliation of documents that are merely withheld, but not destroyed, requires evidence that the documents are actually withheld, rather than—for instance— misplaced.” Id. at 79. A court’s decision on a motion for a sanction such as an adverse inference due to the destruction, loss, or withholding of evidence is discretionary. Duong v. Benihana Nat’l Corp., Civ.

A. No. 21-1088, 2022 U.S. App. LEXIS 10213, at *5 (3d Cir. Apr. 15, 2022) (citing In re Consolidation Coal Co., 123 F.3d 126, 131 (3d Cir. 1997)). III. DECISION Swift contends he sought the production of documents from Defendants regarding how the $977,394 was spent by Xechem India and/or Defendants to prove his claims Defendants were unjustly enriched or are liable under quantum meruit. (ECF No. 454 at 3.) In particular, he alleges Xechem India’s general ledger, bank statements, invoices, records of payment and similar business documents are necessary to explain how the money was spent. (Id.) Not having received these documents in discovery, he moves for an adverse inference sanction and raises several arguments in support of the motion.

First, Swift argues Defendants production of approximately 2,566 pages of documents— of which only 315 pages were responsive and many were duplicates—supports his motion for an adverse inference. (Id.

Free access — add to your briefcase to read the full text and ask questions with AI

SWIFT v. PANDEY, (D.N.J. 2022).

SWIFT v. PANDEY (SWIFT v. PANDEY) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related